Learning from bedaquiline in South Africa – comprehensive health systems for new antibiotics – 2020 – ReAct
Bedaquiline - Goulooze - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library
Bedaquiline: A New Hope to Treat Multi-Drug Resistant Tuberculosis | Bentham Science
TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of Mycobacterium tuberculosis F-ATP Synthase | Antimicrobial Agents and Chemotherapy
A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity - ScienceDirect
Frontiers | M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance
The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics | Nature Reviews Chemistry
Bedaquiline - Goulooze - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library
Bedaquiline | Uses, Brand Names, Mechanism Of Action
Antibiotics | Free Full-Text | Novel Treatments against Mycobacterium tuberculosis Based on Drug Repurposing
Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance - ScienceDirect
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs - ScienceDirect
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence | European Respiratory Society
Frontiers | Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis | SpringerLink
Tuberculosis Drugs and Mechanisms of Action | NIH: National Institute of Allergy and Infectious Diseases
Effect of Disease State on the Pharmacokinetics of Bedaquiline in Renal-Impaired and Diabetic Rats | ACS Omega
A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity - ScienceDirect
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects - The Lancet Infectious Diseases
Frontiers | Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
Preserved efficacy and reduced toxicity with intermittent linezolid dosing in combination with bedaquiline and pretomanid in a murine TB model - preLights
Science News Highlights - Mechanism of action of tuberculosis drug Using Cryo-EM, the authors show that how anti-TB drug bedaquiline binds to ATP synthase and disrupts its synthesis of the molecule ATP.
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence | European Respiratory Society
Novel Treatments for Drug-Resistant Tuberculosis - Jeremy M. Clain, Patricio Escalante, 2016
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline | NEJM
